| Email Article | Print |
ID, HIV experts urge more resources for TB
March 24, 2008IDSA and HIVMA statement on World TB Day
In honor of World TB Day 2008 (March 24), the Infectious Diseases Society of America (IDSA) and the HIVMA Medicine Association (HIVMA) are urging U.S. policymakers to step up the fight against tuberculosis by committing substantial resources against the disease both at home and abroad.
With drug-resistant strains of TB on the rise and progress in detecting new cases on the decline, resources are needed to support TB care, surveillance, infection control, and research into new drugs, diagnostics, and vaccines.
"The standard test for diagnosing TB is more than 100 years old and it fails to adequately detect the disease in children and people with HIV. The newest class of TB drugs is more than 40 years old and does a poor job on drug-resistant TB. Today's TB vaccine is more than 85 years old and is not highly effective, and for that reason it is not recommended for routine use in the United States," said Carol Dukes Hamilton, MD, an IDSA and HIVMA spokesperson who works on TB and HIV in the United States and the developing world.
TB remains one of the leading infectious disease killers worldwide, with about 9 million new cases and almost 2 million deaths each year. In the U.S. alone, about 10 million to 14 million people are estimated to be infected with latent tuberculosis. Active TB can be easily passed to others-even healthy adults and children-simply by breathing the same air. The World Health Organization estimates that nearly half a million cases of TB are resistant to first-line drugs.
In the developing world, TB is the leading killer of people with HIV. The two epidemics fuel each other in a vicious cycle. People with HIV are more susceptible to getting sick and dying from TB if they are exposed, and TB bacteria accelerate the progression of HIV to AIDS. Absent a comprehensive plan to control tuberculosis, this deadly infection threatens to undermine the gains that have been made in saving the lives of persons living with HIV in the developing world.
Legislation in both the House and Senate would devote substantial resources-$4 billion over five years-to stopping TB in the developing world through the President's Plan for AIDS Relief (PEPFAR). PEPFAR supports HIV/AIDS programs in 15 countries that comprise 21 percent of the global TB burden and 24 percent of the world's annual TB deaths. The program offers millions more in support of HIV prevention and treatment activities in scores of other developing countries.
"The U.S. government has been a leader in stopping HIV/AIDS in the developing world," said Dr. Hamilton. "We must show the same bold leadership on tuberculosis; otherwise, we run the risk of losing ground on control of tuberculosis-including highly drug-resistant TB-and HIV/AIDS."
Unfortunately, the Bush administration's proposed budget for fiscal year 2009 includes significant cuts for TB and other infectious disease programs. Especially hard-hit is the U.S. Centers for Disease Control and Prevention (CDC), which would see a cut of nearly half a billion dollars in its total budget. IDSA supports increasing CDC's overall budget by 15 percent and devoting $300 million for efforts to prevent, control, and eliminate tuberculosis in the United States. Likewise, IDSA supports increased resources for the National Institutes of Health (NIH)'s TB programs. NIH expects to spends about $187 million on TB in fiscal year 2009, including $17 million on efforts to find a new vaccine.
Infectious Diseases Society of America
"The standard test for diagnosing TB is more than 100 years old and it fails to adequately detect the disease in children and people with HIV. The newest class of TB drugs is more than 40 years old and does a poor job on drug-resistant TB. Today's TB vaccine is more than 85 years old and is not highly effective, and for that reason it is not recommended for routine use in the United States," said Carol Dukes Hamilton, MD, an IDSA and HIVMA spokesperson who works on TB and HIV in the United States and the developing world.
TB remains one of the leading infectious disease killers worldwide, with about 9 million new cases and almost 2 million deaths each year. In the U.S. alone, about 10 million to 14 million people are estimated to be infected with latent tuberculosis. Active TB can be easily passed to others-even healthy adults and children-simply by breathing the same air. The World Health Organization estimates that nearly half a million cases of TB are resistant to first-line drugs.
In the developing world, TB is the leading killer of people with HIV. The two epidemics fuel each other in a vicious cycle. People with HIV are more susceptible to getting sick and dying from TB if they are exposed, and TB bacteria accelerate the progression of HIV to AIDS. Absent a comprehensive plan to control tuberculosis, this deadly infection threatens to undermine the gains that have been made in saving the lives of persons living with HIV in the developing world.
Legislation in both the House and Senate would devote substantial resources-$4 billion over five years-to stopping TB in the developing world through the President's Plan for AIDS Relief (PEPFAR). PEPFAR supports HIV/AIDS programs in 15 countries that comprise 21 percent of the global TB burden and 24 percent of the world's annual TB deaths. The program offers millions more in support of HIV prevention and treatment activities in scores of other developing countries.
"The U.S. government has been a leader in stopping HIV/AIDS in the developing world," said Dr. Hamilton. "We must show the same bold leadership on tuberculosis; otherwise, we run the risk of losing ground on control of tuberculosis-including highly drug-resistant TB-and HIV/AIDS."
Unfortunately, the Bush administration's proposed budget for fiscal year 2009 includes significant cuts for TB and other infectious disease programs. Especially hard-hit is the U.S. Centers for Disease Control and Prevention (CDC), which would see a cut of nearly half a billion dollars in its total budget. IDSA supports increasing CDC's overall budget by 15 percent and devoting $300 million for efforts to prevent, control, and eliminate tuberculosis in the United States. Likewise, IDSA supports increased resources for the National Institutes of Health (NIH)'s TB programs. NIH expects to spends about $187 million on TB in fiscal year 2009, including $17 million on efforts to find a new vaccine.
Infectious Diseases Society of America
Tuberculosis News and Current Tuberculosis Events RSSPilot study reinforces use of portable anteroom HEPA filtration
Amidst an increase in new tuberculosis cases, researchers have begun investigating the effectiveness of new operating room filtration systems designed to protect staff and patients.
X-rays power discoveries at Chicago's Field Museum
Digital medical imaging and information technology from Carestream Health, Inc., is playing a key role in helping The Field Museum of Chicago discover and analyze secrets hidden within its world-class collections.
Study shows common vitamin and other micronutrient supplements reduce risks of TB recurrence
New findings show a link between micronutrient supplementation and reduced risk of recurrence during tuberculosis chemotherapy, according to a study published in the June 1 issue of The Journal of Infectious Diseases, now available online.
NIAID describes research priorities to fight drug-resistant tuberculosis
Tuberculosis (TB) has long been one of the world's great killers. Now, forms of drug-resistant TB--multidrug (MDR) and extensively drug-resistant (XDR)--are occurring at an ominous and accelerating rate.
Scientists test device to track medication adherence in patients with HIV/AIDS
Most of us have missed a dose of antibiotic or forgotten to take a daily vitamin. But when the stakes are higher - as they are for people with HIV/AIDS - a skipped pill could mean the difference between health and hazard for the entire population.
University of Arizona scientist shares in discovery of microbe filaments' power
Researchers from The University of Arizona and Columbia University have discovered that tiny filaments on bacteria can bundle together and pull with forces far stronger than experts had previously thought possible.
Researchers pilot new electronic system for infectious illness
Researchers at Harvard Pilgrim Health Care, Harvard Medical School, Atrius Health, and the Massachusetts Department of Public Health have created and tested a set of computer programs that use electronic medical records to help clinicians detect contagious illness and automatically report them to public health departments.
'Healing clays' show promise for fighting deadly MRSA superbug infections, other diseases
Mud may be coming to a medicine cabinet or pharmacy near you. Scientists in Arizona report that minerals from clay could form the basis of a new generation of inexpensive, highly-effective antimicrobials for fighting MRSA infections that are moving out of health care settings and into the community.
Better and faster: Distinguishing non-TB pulmonary disease from TB
A diagnostic kit shows new promise for distinguishing between tuberculosis (TB) and its infections from disease caused by related mycobacteria family, which mimic TB and other lung disease in symptoms but require distinctly different clinical treatments.
Smear campaign: Faster detection of multidrug-resistant TB for public health
There is a new tool in the arsenal to fight multidrug-resistant tuberculosis (MDR-TB): a rapid diagnostic test that can function in high-burden settings such as public health clinics.
More Tuberculosis News Articles
 | The Air We Breathe: A Novel by Andrea Barrett |
 | Illness as Metaphor and AIDS and Its Metaphors by Susan Sontag |
 | Haunted Sanatorium |
 | Towns of the Sandia Mountains (NM) (Images of America) by Mike Smith |
 | Identification Problems in the Social Sciences by Charles F. Manski |
 | Virgin River: A Barnaby Skye Novel (Skye's West) by Richard S. Wheeler |
 | Behold the Many: A Novel by Lois-Ann Yamanaka |
 | The Return of the White Plague: Global Poverty and the 'New' Tuberculosis |
 | The Forgotten Plague: How the Battle Against Tuberculosis Was Won - And Lost by Frank Ryan |
| 13 is too young to die by Isaacsen-Bright |
| © 2008 BrightSurf.com |